UCB SA (EBR:UCB)
Belgium
· Delayed Price · Currency is EUR 136.30
-2.10 (-1.52%)
Apr 17, 2025, 5:35 PM CET
UCB SA Employees
As of December 31, 2024, UCB SA had 9,378 total employees, including 9,052 full-time and 326 part-time employees. The number of employees increased by 295 or 3.25% compared to the previous year.
Employees
9,378
Change (1Y)
295
Growth (1Y)
3.25%
Revenue / Employee
€667,607
Profits / Employee
€115,572
Market Cap
25.90B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| argenx SE | 1,599 |
| Fagron NV | 3,828 |
| Ion Beam Applications | 2,145 |
| Nyxoah | 184 |
| Hyloris Pharmaceuticals | 49 |
| Onward Medical | 99 |
| Sequana Medical NV | 62 |
| Celyad Oncology | 19 |
UCB SA News
- 6 weeks ago - Europe-Based UCB's Bimzelx Data Reveals Sustained Skin Clearance In Inflammatory Skin Disorders - Benzinga
- 6 weeks ago - BIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in Hidradenitis Suppurativa, and Reduction in Disease Burden - Benzinga
- 6 weeks ago - UCB SA (UCBJF) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 6 weeks ago - Full Year 2024 Ucb SA Earnings Call Transcript - GuruFocus
- 7 weeks ago - Decoding United Community Banks Inc (UCB): A Strategic SWOT Insight - GuruFocus
- 3 months ago - United Community Banks, Inc. (UCB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - United Community Banks Non-GAAP EPS of $0.63 beats by $0.07, revenue of $239.47M misses by $3.26M - Seeking Alpha
- 3 months ago - UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx) - Benzinga